Frontiers in Immunology (Mar 2024)

Mathematical modeling in autoimmune diseases: from theory to clinical application

  • Yaroslav Ugolkov,
  • Yaroslav Ugolkov,
  • Antonina Nikitich,
  • Antonina Nikitich,
  • Cristina Leon,
  • Gabriel Helmlinger,
  • Kirill Peskov,
  • Kirill Peskov,
  • Kirill Peskov,
  • Kirill Peskov,
  • Victor Sokolov,
  • Victor Sokolov,
  • Alina Volkova,
  • Alina Volkova

DOI
https://doi.org/10.3389/fimmu.2024.1371620
Journal volume & issue
Vol. 15

Abstract

Read online

The research & development (R&D) of novel therapeutic agents for the treatment of autoimmune diseases is challenged by highly complex pathogenesis and multiple etiologies of these conditions. The number of targeted therapies available on the market is limited, whereas the prevalence of autoimmune conditions in the global population continues to rise. Mathematical modeling of biological systems is an essential tool which may be applied in support of decision-making across R&D drug programs to improve the probability of success in the development of novel medicines. Over the past decades, multiple models of autoimmune diseases have been developed. Models differ in the spectra of quantitative data used in their development and mathematical methods, as well as in the level of “mechanistic granularity” chosen to describe the underlying biology. Yet, all models strive towards the same goal: to quantitatively describe various aspects of the immune response. The aim of this review was to conduct a systematic review and analysis of mathematical models of autoimmune diseases focused on the mechanistic description of the immune system, to consolidate existing quantitative knowledge on autoimmune processes, and to outline potential directions of interest for future model-based analyses. Following a systematic literature review, 38 models describing the onset, progression, and/or the effect of treatment in 13 systemic and organ-specific autoimmune conditions were identified, most models developed for inflammatory bowel disease, multiple sclerosis, and lupus (5 models each). ≥70% of the models were developed as nonlinear systems of ordinary differential equations, others – as partial differential equations, integro-differential equations, Boolean networks, or probabilistic models. Despite covering a relatively wide range of diseases, most models described the same components of the immune system, such as T-cell response, cytokine influence, or the involvement of macrophages in autoimmune processes. All models were thoroughly analyzed with an emphasis on assumptions, limitations, and their potential applications in the development of novel medicines.

Keywords